Company Description
ReShape Lifesciences Inc. provides products and services that manage and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally.
The company’s product portfolio includes Lap-Band System to treat obesity and invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band to optimize an individual’s comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.
It is involved in the development of the ReShape Obalon Balloon System, which consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and the Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus.
ReShape Lifesciences Inc. was founded in 2002 and is headquartered in Irvine, California.
| Country | United States |
| Founded | 2002 |
| IPO Date | Nov 15, 2007 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 18 |
| CEO | Paul Hickey |
Contact Details
Address: 18 Technology Drive, Suite 110 Irvine, California 92618 United States | |
| Phone | 949 429 6680 |
| Website | reshapelifesciences.com |
Stock Details
| Ticker Symbol | RSLS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001371217 |
| CUSIP Number | 76090R408 |
| ISIN Number | US76090R4083 |
| Employer ID | 48-1293684 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Paul F. Hickey | Chief Executive Officer, President and Director |
| Dan W. Gladney | Executive Chair |
| Thomas Stankovich | Senior Vice President and Chief Financial Officer |
| Al Diaz | Vice President of Operations and Research & Development |
| Dr. Dov Gal D.V.M., M.B.A. | Vice President of Regulatory Clinical Quality and Compliance Officer |
| Naqeeb A. Ansari | Senior Vice President of Global Commercial Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |
| Jun 25, 2021 | EFFECT | Notice of Effectiveness |